
Onco-Innovations partner begins A83B4C63 scale-up
Onco-Innovations partner begins A83B4C63 scale-up

Onco-Innovations partner begins A83B4C63 scale-up
NexgenRx Announces Significant Third Quarter Revenue and EBITDA Growth
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
Hemostemix's ACP-01 dementia trial to be led by Shankle
Briacell, Receptor.AI to work on kinase inhibitors
BioSyent Releases Financial Results for Q3 and YTD 2025
Innovotech closes $200K convertible debenture financing
GREY WOLF ANIMAL HEALTH REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
Well Health talks clinic digitization, patient openings
Preveceutical to close BioGene deal effective Nov. 24
Bionxt Solutions receives Eurasian patent grant
Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia
Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500(TM)
Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics